Vijay Patil - Concepedia

Author

Vijay Patil

Also Known As

J Divatia, V Patil, V. Patil, V.M. Patil, Vaibhav Patil, Vibhavari V. Patil, Vijay M Patil, Vijay M. Patil, Vijay Maruthi Patil, Vijay Patil

109

Publications

Citations

H-Index

Concepts

All Affiliations

Tata Memorial Hospital Homi Bhabha National Institute Bharati Vidyapeeth Deemed University Advanced Centre for Treatment, Research and Education in Cancer Malabar Cancer Centre

About

Vijay Patil is an author at Tata Memorial Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	442
2	Health Sciences	5	5	125
3	Engineering	1	1	10
4	Natural Sciences	1	1	17
5	Nursing	1	1	55

Vijay Patil

Publications

845

Citations

H-Index

Page 1

	Year	Citations
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations Kanika Bajaj Pahuja, Thong Tien Nguyen, Bijay S. Jaiswal, Cancer Cell Signal TransductionProtein TransportIntracellular TraffickingCellular BiochemistryJuxtamembrane Domain Mutations	2018	159
Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives Vijay Patil, Kalpana Tilekar, Sonali Mehendale-Munj, European Journal of Medicinal Chemistry DerivativesNew 5-Benzylidene-2,4-thiazolidinedioneOrganic ChemistryHeterocycle ChemistryPharmacology	2010	138
Stepwise cox regression analysis in SPSS Vijay Patil, Sampada Dessai, Vijai Simha Cancer Research Statistics and Treatment NursingPatient SafetyCox AnalysisOutcomes ResearchArticle Touches	2018	55
Treatment of advanced non-small-cell lung cancer Kumar Prabhash, Amish Vora, Sewanti Limaye, Cancer Research Statistics and Treatment Preclinical TherapeuticsSurgical OncologyAdvanced Lung DiseaseCancer ManagementPathology	2021	45
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment Vanita Noronha, Anuradha Choughule, Vijay Patil, OncoTargets and Therapy	2017	41
Guidelines for treatment of recurrent or metastatic head and neck cancer Kumar Prabhash, Purvish M. Parikh, Vijay Patil, Indian Journal of Cancer Neck CancerMedicineNasopharyngeal CancerNeck PathologyHead And Neck Cancer	2014	35
ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes Amit Joshi, Nikhil Pande, Vanita Noronha, ecancermedicalscience	2019	34
The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients Vanita Noronha, Amit Joshi, Anant Gokarn, Chemotherapy Research and Practice Neuro-oncologyMedicineBrain MetastasisPathologyEgfr Mutant Nsclc	2014	33
Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent Chemoradiotherapy Abhishek Mahajan, Ankur Chand, Ujjwal Agarwal, Frontiers in Oncology	2022	27
Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity Sarbani Ghosh Laskar, Devendra Chaukar, Mandar Deshpande, European Journal of Cancer Surgical OncologyRadiation TherapyMedicineOral CavityPhase Iii	2022	25

Page 1